Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Temperature | 8 | 2009 | 776 | 1.260 |
Why?
|
| Schizophrenia | 22 | 2009 | 6874 | 1.020 |
Why?
|
| Antipsychotic Agents | 17 | 2009 | 3058 | 0.800 |
Why?
|
| Cornea | 4 | 2009 | 1497 | 0.580 |
Why?
|
| Body Temperature Regulation | 3 | 2009 | 252 | 0.520 |
Why?
|
| Hospitals, Psychiatric | 3 | 2007 | 332 | 0.520 |
Why?
|
| Schizophrenic Psychology | 9 | 2009 | 1677 | 0.460 |
Why?
|
| Temperature | 4 | 2008 | 2207 | 0.430 |
Why?
|
| Akathisia, Drug-Induced | 2 | 2009 | 67 | 0.400 |
Why?
|
| Schizophrenia, Paranoid | 2 | 2001 | 104 | 0.390 |
Why?
|
| Oxazolidinones | 2 | 2009 | 96 | 0.390 |
Why?
|
| Serotonin Receptor Agonists | 2 | 2009 | 154 | 0.380 |
Why?
|
| Patient Admission | 4 | 2007 | 1380 | 0.360 |
Why?
|
| Tryptamines | 2 | 2009 | 88 | 0.350 |
Why?
|
| Clozapine | 4 | 2004 | 498 | 0.340 |
Why?
|
| Creatine Kinase | 4 | 2003 | 694 | 0.330 |
Why?
|
| Radiosurgery | 1 | 2018 | 1309 | 0.320 |
Why?
|
| Propranolol | 1 | 2009 | 502 | 0.300 |
Why?
|
| Commitment of Mentally Ill | 1 | 2007 | 93 | 0.300 |
Why?
|
| Mentally Ill Persons | 1 | 2007 | 126 | 0.290 |
Why?
|
| Patients' Rooms | 1 | 2007 | 63 | 0.290 |
Why?
|
| Pain | 2 | 2020 | 4961 | 0.280 |
Why?
|
| Neuroleptic Malignant Syndrome | 2 | 2003 | 71 | 0.270 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2522 | 0.260 |
Why?
|
| Climate | 2 | 2005 | 147 | 0.250 |
Why?
|
| Muscle Rigidity | 1 | 2003 | 35 | 0.230 |
Why?
|
| Hospitals, Public | 1 | 2005 | 207 | 0.230 |
Why?
|
| Haloperidol | 3 | 2001 | 397 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1239 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2009 | 6030 | 0.220 |
Why?
|
| Mianserin | 1 | 2002 | 52 | 0.210 |
Why?
|
| Perphenazine | 2 | 2001 | 34 | 0.210 |
Why?
|
| Seasons | 2 | 2005 | 1492 | 0.200 |
Why?
|
| Ejaculation | 2 | 2001 | 58 | 0.200 |
Why?
|
| Serotonin Antagonists | 1 | 2002 | 146 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1407 | 0.200 |
Why?
|
| Pyridoxine | 1 | 2001 | 103 | 0.190 |
Why?
|
| Urinary Retention | 1 | 2001 | 110 | 0.190 |
Why?
|
| Sex Reassignment Surgery | 1 | 2023 | 130 | 0.190 |
Why?
|
| Risperidone | 2 | 2001 | 383 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2009 | 1914 | 0.170 |
Why?
|
| Inpatients | 2 | 2009 | 2495 | 0.170 |
Why?
|
| Israel | 6 | 2007 | 795 | 0.160 |
Why?
|
| Sulpiride | 1 | 1997 | 17 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3760 | 0.150 |
Why?
|
| Eosinophilia | 1 | 2001 | 531 | 0.150 |
Why?
|
| Dopamine Antagonists | 1 | 1997 | 296 | 0.140 |
Why?
|
| Palliative Care | 3 | 2020 | 3478 | 0.140 |
Why?
|
| Psychotic Disorders | 5 | 2016 | 3040 | 0.130 |
Why?
|
| Adult | 34 | 2021 | 213712 | 0.130 |
Why?
|
| Cisplatin | 1 | 2021 | 1637 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2007 | 3111 | 0.110 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2009 | 357 | 0.110 |
Why?
|
| Drug Therapy, Combination | 5 | 2005 | 6483 | 0.110 |
Why?
|
| Catatonia | 1 | 1995 | 157 | 0.110 |
Why?
|
| Depressive Disorder | 2 | 2004 | 3748 | 0.100 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2009 | 1204 | 0.100 |
Why?
|
| Male | 34 | 2023 | 349538 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4839 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2020 | 3418 | 0.090 |
Why?
|
| Drug Resistance | 2 | 2009 | 1608 | 0.090 |
Why?
|
| Middle Aged | 22 | 2021 | 213127 | 0.090 |
Why?
|
| Humans | 45 | 2023 | 742088 | 0.090 |
Why?
|
| Trazodone | 1 | 2009 | 66 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2838 | 0.080 |
Why?
|
| Female | 29 | 2023 | 379592 | 0.080 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2002 | 187 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 21596 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6365 | 0.070 |
Why?
|
| Bruxism | 1 | 2006 | 15 | 0.070 |
Why?
|
| Double-Blind Method | 4 | 2009 | 12017 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2008 | 574 | 0.070 |
Why?
|
| Utilization Review | 1 | 2007 | 392 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2009 | 15530 | 0.070 |
Why?
|
| Basal Ganglia Diseases | 2 | 2002 | 149 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 6974 | 0.060 |
Why?
|
| Cholinergic Antagonists | 1 | 2005 | 165 | 0.060 |
Why?
|
| Indans | 1 | 2004 | 96 | 0.060 |
Why?
|
| Feces | 1 | 2010 | 1394 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2010 | 810 | 0.060 |
Why?
|
| Ambulatory Care | 4 | 2009 | 2706 | 0.060 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2006 | 215 | 0.060 |
Why?
|
| Exercise Test | 2 | 2001 | 2075 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2004 | 239 | 0.050 |
Why?
|
| Water | 1 | 2008 | 1388 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 1319 | 0.050 |
Why?
|
| Myoglobinuria | 1 | 2001 | 23 | 0.050 |
Why?
|
| Reference Values | 1 | 2009 | 4982 | 0.050 |
Why?
|
| Skin Temperature | 1 | 2001 | 94 | 0.050 |
Why?
|
| Hallucinations | 1 | 2004 | 360 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2009 | 21719 | 0.050 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2001 | 164 | 0.050 |
Why?
|
| Orgasm | 2 | 2002 | 64 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2001 | 237 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 2001 | 83 | 0.050 |
Why?
|
| Music | 1 | 2004 | 259 | 0.050 |
Why?
|
| Acute Disease | 3 | 2016 | 7141 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2006 | 893 | 0.050 |
Why?
|
| Anal Canal | 1 | 2023 | 376 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.050 |
Why?
|
| Heat Stress Disorders | 1 | 2000 | 50 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2002 | 439 | 0.040 |
Why?
|
| Mental Disorders | 3 | 2006 | 6587 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2007 | 6452 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2007 | 13921 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 1825 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2021 | 891 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2004 | 1791 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8829 | 0.040 |
Why?
|
| Vagina | 1 | 2023 | 825 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 262 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2021 | 53187 | 0.040 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2004 | 1442 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 1995 | 4248 | 0.040 |
Why?
|
| Thioridazine | 1 | 1996 | 33 | 0.030 |
Why?
|
| Morals | 1 | 2019 | 282 | 0.030 |
Why?
|
| Imipramine | 1 | 1996 | 97 | 0.030 |
Why?
|
| Remission Induction | 1 | 2001 | 2384 | 0.030 |
Why?
|
| Piperidines | 1 | 2004 | 1602 | 0.030 |
Why?
|
| Psychometrics | 3 | 2016 | 2999 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 955 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 1737 | 0.030 |
Why?
|
| Spirituality | 1 | 2019 | 405 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56350 | 0.030 |
Why?
|
| Length of Stay | 1 | 2007 | 6294 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2019 | 921 | 0.030 |
Why?
|
| Learning | 1 | 2003 | 1705 | 0.030 |
Why?
|
| Epilepsy | 1 | 2009 | 3301 | 0.030 |
Why?
|
| Prognosis | 3 | 2003 | 29010 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2009 | 8541 | 0.030 |
Why?
|
| Comorbidity | 3 | 2004 | 10372 | 0.030 |
Why?
|
| Chi-Square Distribution | 3 | 2006 | 3510 | 0.030 |
Why?
|
| Time Factors | 3 | 2010 | 40054 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2002 | 2050 | 0.030 |
Why?
|
| Mastectomy | 1 | 2021 | 1789 | 0.030 |
Why?
|
| Personality Inventory | 2 | 2006 | 1026 | 0.030 |
Why?
|
| Neurons | 2 | 2001 | 9325 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 2680 | 0.030 |
Why?
|
| Anxiety | 1 | 2006 | 4279 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 162944 | 0.030 |
Why?
|
| Cytokines | 1 | 2006 | 7317 | 0.020 |
Why?
|
| Heart Rate | 1 | 2001 | 4091 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.020 |
Why?
|
| Risk Factors | 3 | 2007 | 72145 | 0.020 |
Why?
|
| Electroconvulsive Therapy | 1 | 1995 | 472 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2451 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2009 | 62966 | 0.020 |
Why?
|
| Adolescent | 5 | 2009 | 85649 | 0.020 |
Why?
|
| Sex Factors | 2 | 2019 | 10392 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 10578 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8621 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2006 | 5425 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 474 | 0.020 |
Why?
|
| Tooth Attrition | 1 | 2006 | 7 | 0.020 |
Why?
|
| Depression | 1 | 2006 | 7733 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2004 | 5024 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20928 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11001 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3527 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 748 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 23320 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7770 | 0.020 |
Why?
|
| Terminal Care | 1 | 2017 | 1688 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 1465 | 0.020 |
Why?
|
| Brain | 2 | 2001 | 26343 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1871 | 0.010 |
Why?
|
| Penile Erection | 1 | 2002 | 97 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2010 | 1032 | 0.010 |
Why?
|
| Libido | 1 | 2002 | 121 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 242 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2001 | 352 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2001 | 178 | 0.010 |
Why?
|
| Marital Status | 1 | 2002 | 437 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 4929 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2000 | 108 | 0.010 |
Why?
|
| Panic Disorder | 1 | 2004 | 616 | 0.010 |
Why?
|
| Hospitalization | 2 | 2002 | 10232 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 1024 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15056 | 0.010 |
Why?
|
| Observer Variation | 1 | 2006 | 2593 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2372 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 12958 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3862 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2030 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2001 | 545 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 2295 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2004 | 2290 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10943 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14720 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2536 | 0.010 |
Why?
|
| Dopamine | 1 | 2001 | 1589 | 0.010 |
Why?
|
| Leukocytes | 1 | 2002 | 2039 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2001 | 2964 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 5872 | 0.010 |
Why?
|
| Suicide | 1 | 2001 | 1475 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 15194 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2001 | 3300 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 12242 | 0.010 |
Why?
|
| Child | 2 | 2006 | 77478 | 0.000 |
Why?
|
| Registries | 1 | 2001 | 8077 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2000 | 9144 | 0.000 |
Why?
|
| HIV Infections | 1 | 2010 | 16678 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 2002 | 77098 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 24913 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 29087 | 0.000 |
Why?
|
| Animals | 2 | 2001 | 168561 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81045 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_